Valneva SE (VALN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
VALN Profit Margin, ROE & Profitability Analysis
VALN vs Healthcare Sector: How Valneva SE Compares
How Valneva SE compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Valneva SE Stock Overvalued? VALN Valuation Analysis 2026
Based on fundamental analysis, Valneva SE has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Valneva SE Balance Sheet: VALN Debt, Cash & Liquidity
VALN Revenue Growth, EPS Growth & YoY Performance
VALN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Valneva SE (CIK: 0001836564)
📋 Recent SEC Filings
❓ Frequently Asked Questions about VALN
What is the AI rating for VALN?
Valneva SE (VALN) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are VALN's key strengths?
Claude: Analysis in progress.
What are the risks of investing in VALN?
Claude: Analysis in progress.
What is VALN's revenue and growth?
Valneva SE reported revenue of N/A.
Does VALN pay dividends?
Valneva SE does not currently pay dividends.
Where can I find VALN SEC filings?
Official SEC filings for Valneva SE (CIK: 0001836564) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is VALN's EPS?
Valneva SE has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is VALN's fundamental grade?
Based on our AI fundamental analysis in May 2026, Valneva SE has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is VALN stock overvalued or undervalued?
Valuation metrics for VALN: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is VALN's AI grade for 2026?
Our dual AI analysis gives Valneva SE a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is VALN's free cash flow?
Valneva SE's operating cash flow is N/A, with capital expenditures of N/A.
How does VALN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).